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Abstract
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The collection of components required to carry out the intricate processes involved in generating
and maintaining a living, breathing and, sometimes, thinking organism is staggeringly complex.
Where do all of the parts come from? Early estimates stated that about 100,000 genes would be
required to make up a mammal; however, the actual number is less than one-quarter of that, barely
four times the number of genes in budding yeast. It is now clear that the ‘missing’ information is
in large part provided by alternative splicing, the process by which multiple different functional
messenger RNAs, and therefore proteins, can be synthesized from a single gene.
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Alternative splicing of precursor messenger RNA (pre-mRNA) was first described almost 30
years ago, when it was discovered that membrane-bound and secreted antibodies are
encoded by the same gene1,2. Soon after, more examples of this phenomenon were
described: for instance, the calcitonin/calcitonin-related polypeptide gene encodes two
peptide hormones, which are expressed in a tissue-specific manner3. In both of these
examples, the differential inclusion and exclusion of exonic sequences through alternative
splicing (and alternative polyadenylation) is responsible for doubling the number of proteins
encoded by the genes. Although it was at one time considered unusual, the estimated
number of genes that encode more than one protein (or protein isoform) as a result of
alternative splicing of a pre-mRNA has steadily risen over time. Recent studies using highthroughput sequencing indicate that 95–100% of human pre-mRNAs that contain sequence
corresponding to more than one exon are processed to yield multiple mRNAs4,5. And not
only do most genes encode pre-mRNAs that are alternatively spliced, but also the number of
mRNA isoforms encoded by a single gene can vary from two to several thousand. One
spectacular example is the Drosophila melanogaster gene Down syndrome cell adhesion
molecule (Dscam), which can generate 38,016 distinct mRNA isoforms6, a number far in
excess of the total number of genes (~14,500) in the organism.
If the enormous diversity of proteins that can be generated by alternative splicing is
considered together with other processes such as the use of alternative transcription start
sites, alternative polyadenylation and RNA editing, as well as post-translational
modification (such as phosphorylation, ubiquitylation and SUMOylation; a largely
unexplored area), the number of functionally distinct proteins that could be encoded by the
genome is staggering. Although the relative extent to which these and other mechanisms and
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modifications contribute to increasing protein diversity is unclear, alternative splicing is one
of the main sources of proteomic diversity in multicellular eukaryotes.
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In this Review, we discuss the complexity of alternative splicing and consider the
mechanisms that are known, or suspected, to be involved in regulating the choice of splice
site. We then outline the important outstanding questions in the field and speculate on the
evolutionary implications of expanded proteomic diversity.

Diverse manifestations of alternative splicing
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Alternative splicing involves the differential use of splice sites to create protein diversity.
Nearly all instances of alternative splicing result from the use of one or more of four basic
modules: alternative 5′ splice-site choice, alternative 3′ splice-site choice, cassette-exon
inclusion or skipping, and intron retention (Fig. 1). Genes that encode a small number of
mRNA isoforms typically contain only one or two of these modules. For instance, two
mRNAs could be synthesized from a gene containing a single cassette exon: one mRNA that
contains the exonic sequence, and one that lacks it. By contrast, tremendously diverse
mRNA repertoires can be generated from genes constructed with many modules. For
example, the human gene KCNMA1 (also known as SLO) contains numerous modules,
including alternative 5′ splice sites, alternative 3′ splice sites and cassette exons, and more
than 500 mRNA isoforms of KCNMA1 can be generated7,8 (Fig. 2a). Similarly, the 38,016
potential Dscam mRNA isoforms are synthesized from a gene containing 95 cassette exons,
which are spliced from the pre-mRNA in a mutually exclusive manner (that is, each mRNA
isoform contains sequence corresponding to only one cassette exon)6 (Fig. 2b). An even
more elaborate manifestation of alternative splicing is exemplified by the D. melanogaster
gene modifier of mdg4 (mod(mdg4)), which encodes 28 mRNAs. These are generated by
trans-splicing of sequence corresponding to a group of common exons, present on one premRNA, to sequence corresponding to one set of 28 variable exons, present on separate premRNAs9,10 (Fig. 2c). It is not known whether similar trans-splicing events occur in other
multicellular eukaryotes.

Mechanisms of alternative splicing
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It is unclear how much of alternative splicing is ‘constitutive’ (that is, the extent to which
multiple isoforms are produced at the same ratios in all or most cell types). This is because
the most extensively studied cases of alternative splicing are regulated alternative splicing
events. Regulation in this context means that distinct splicing patterns are observed in
different cellular environments. Such regulation can be tissue specific (for example a
sequence corresponding to a particular exon is included in muscle but not brain) or dictated
by developmental11 or differentiation-specific12,13 cues. In addition, some alternative
splicing patterns have been shown to be modulated in response to external stimuli, such as
depolarization of neurons14 or activation of signal transduction cascades15,16.
The biochemical mechanisms that control splice-site usage, and therefore alternative
splicing, are complex and in large part remain poorly understood17. It is clear that there
cannot be specific and distinct factors dedicated to each of the more than 100,000 alternative
splicing decisions that occur in human cells; several genomes worth of regulatory proteins
would be required if this were the case. Therefore, it is expected that only a small number of
factors are specifically dedicated to one or a few alternative splicing events, such as the
factors that dictate the sex-determination cascade in D. melanogaster11. Accordingly, it is
not surprising that a small number of proteins have repeatedly been found to be responsible
(at least in part) for the regulation of a large number of alternative splicing events17,18
(Table 1). Indeed, few tissue-specific RNA-binding proteins have been identified. Instead,
most known regulators of alternative splicing, such as SR proteins and heterogeneous
Nature. Author manuscript; available in PMC 2012 September 17.
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nuclear ribonucleoproteins (hnRNPs), are ubiquitously expressed, although their relative
abundances can fluctuate in different tissues. Notable exceptions are NOVA19, nPTB (also
known as PTBP2)20,21, FOX1 and FOX2 (also known as A2BP1 and A2BP2)22,23, ESRP1
and ESRP2 (ref. 24), and nSR100 (also known as SRRM4)25, the genes encoding which are
all expressed in a tissue-specific manner. How can this handful of splicing regulators be
responsible for controlling the plethora of alternative splicing events that occur?
The most studied splicing regulators so far are members of the SR-protein and hnRNP
families. SR proteins (so named because they contain domains composed of extensive
repeats of serine and arginine) are RNA-binding proteins that are generally thought to
activate splicing by binding to the sequences corresponding to exons and recruiting
components of the core splicing machinery (the spliceosome)26. By contrast, hnRNPs,
which are also RNA-binding proteins, are generally thought to repress splicing by binding to
sequences corresponding to exons or introns and interfering with the ability of the core
splicing machinery to engage splice sites27; however, the mechanisms by which hnRNPs
negatively regulate splicing are far from understood.
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The existence of ‘opposing’ classes of splicing regulatory factors, and the abundant evidence
that these factors are involved in a large number of splicing decisions, has led to the
elaboration of a straightforward ‘yin–yang’ model of alternative splicing28. In this model,
splice-site usage is determined by the number of positively acting sites (splicing enhancers
that are bound by SR proteins) and negatively acting sites (splicing silencers bound by
hnRNPs). When positive sites outnumber negative sites, splicing occurs; when negative sites
predominate, splicing is inhibited. Although this model is comforting in its simplicity and
has some predictive value, it vastly understates the biochemical complexity of splicing
regulation29,30.
The number of mechanisms that are known to be involved in splicing regulation
approximates the number of specific splicing decisions that have been analysed in any
detail. These mechanisms range from straightforward ones, such as steric blocking of splice
sites31 or positive recruitment of the splicing machinery32, to more complicated ones, such
as formation of ‘dead-end’ complexes33–35, blocking of splice-site communication36 or
facilitation of splice-site communication37. Even these mechanisms are poorly understood at
a detailed biochemical level (for example, what distinguishes dead-end complexes from
productive complexes remains unclear).

NIH-PA Author Manuscript

The picture becomes even cloudier when splicing (and alternative splicing) is viewed not as
a static process but as a highly dynamic process encompassing a large (yet to be defined)
number of kinetic steps38. It is now clear that many factors can have marked effects on
splicing patterns; these include transcription rate39, core-splicing-machinery levels40,41,
intron size42 and competition between splice sites43. In terms of competition, it was recently
shown that the effects of some strong splicing control elements (strong splicing silencers)
are apparent only when a competing splice site is present upstream of the affected site43
(Fig. 3a). These studies also showed that a ‘classical’ silencer (to which an hnRNP binds)
did not function by occluding, or otherwise inactivating, the affected site but rather by
impairing a non-rate-limiting step in the overall splicing reaction. Importantly, when both
competing sites were ‘silenced’, the original pattern of splicing was restored43, with no
reduction in the extent of splicing (Fig. 3a, bottom right). These results indicate that kinetic
parameters have determining roles in splice-site choice.
When viewed from this kinetic perspective, the effects of transcription rate on alternative
splicing become straightforward to rationalize. The folding of the nascent transcript, and
therefore the accessibility of binding sites to the spliceosome and splicing regulators, could
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be determined by the rate at which the nascent transcript is exposed. In this way, ‘small’
changes could render certain splice sites at a competitive advantage or disadvantage relative
to other splice sites. Recent studies have also indicated that exons in the nascent transcript
become tethered to the elongating transcription complex as they emerge from RNA
polymerase44. Although it seems plausible that this tethering is required for the exonic
sequence to be included in the mRNA — or else become lost in the nuclear environment —
the mechanisms involved in tethering exonic RNA are unknown. We propose that when
RNA polymerase quickly traverses exons in the gene, the transcribed exons evade capture
and are skipped; however, when they are transcribed slowly, they are efficiently tethered and
the corresponding sequence is included in the mRNA (Fig. 3b).
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It is now well established that chromatin structure is highly dynamic and can affect the rate
of transcription, which in turn can influence the pattern of alternative splicing. Indeed, in a
study in which a short interfering RNA was used to induce heterochromatin formation, this
change in chromatin structure correlated with a reduced ability of the transcription
elongation complex to proceed along the DNA and with corresponding changes in the
patterns of alternative splicing45. Moreover, it has recently been shown that exons are
specifically marked by histone H3 trimethylated at lysine residue 36 (H3K36me3) in a
transcription-dependent manner. This modification of the histone was found to occur more
frequently on histones that are packaged with constitutive exons (that is, those that are
constitutively present in mRNA) rather than alternative exons (those that are not always
present in the mRNA)46–48.
Accordingly, we speculate that a large proportion of regulated alternative splicing events
might be determined not by tissue-specific or developmental-stage-specific splicing
regulators but rather by tissue-specific or stage-specific differences in transcription rates,
which could be dictated by local chromatin modifications (Fig. 3b). It will be interesting to
explore whether transcription rates differ markedly between brain and muscle, which have
particularly high levels of alternative splicing, and tissues where alternative splicing is less
prevalent.
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The effects on alternative splicing of depleting core spliceosome proteins40,41 also become
interpretable when splice-site choice is viewed in terms of kinetic competition. If the
splicing machinery is present at a saturating concentration, its recruitment would not be a
rate-limiting step, so other parameters would determine splicing patterns. But, if the
concentration of components of the core splicing machinery becomes limiting, it seems
certain that specific splice-site pairs would be more effective at recruiting constituents of the
spliceosome, resulting in altered patterns of splicing. As is the case for transcription, it will
be interesting to uncover the relative concentrations of spliceosomal components in different
cell types and at different stages of organism development.
A final example of the importance of kinetics in alternative splicing comes from studies of
the D. melanogaster gene Dscam (Fig. 3c), which (as indicated earlier) encodes more than
38,000 mRNA isoforms. This remarkable diversity is mainly generated by mutually
exclusive splicing of pre-mRNA sequence corresponding to four large, independently
controlled clusters of alternative exons6,49. The mutually exclusive splicing of one of these
exonic sequence clusters, that corresponding to exon 6, is mediated by competing RNA
secondary structures that form between a single docking site and one of the selector
sequences located upstream of each of the 48 alternative exonic sequences50,51 (Fig. 3c) in
the mRNA. But it is not understood how the selector sequence is chosen to be the one that
will interact with the docking site. In this case, every aspect of the process from the strength
of each docking-site–selector sequence pair to the rate of transcription through the exon 6
cluster and the distance from each selector sequence to the docking site is likely to have a
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role. To further complicate matters, the hnRNP HRP36 (also known as HRB87F) actively
represses all 48 exonic sequences (Fig. 3c), and depletion of this protein results in the
inclusion of multiple exonic sequences52. Unexpectedly, however, when an SR protein was
depleted together with HRP36, correct splicing was found to be restored52. These results not
only show that SR proteins and hnRNPs have balancing roles but also indicate that the
exonic sequences that are not selected are not ‘dormant’. The simplest explanation for these
findings is that the selected exonic sequence has a competitive advantage over the nonselected exonic sequences such that its splicing to the exonic sequences that flank the cluster
proceeds faster than the joining of exonic sequences within the cluster. It seems probable
that many, if not all, cases of mutually exclusive splicing are determined by such kinetic
parameters, although the details will undoubtedly differ.
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Last, before leaving the mechanistic aspects of alternative splicing, it should be noted that
we have understated the complexity of the mechanisms involved. Nearly all ‘activators’ of
splicing can, in some cases, function as repressors, and nearly all ‘repressors’ have been
shown to function as activators. Particularly striking examples are the U1 small nuclear RNP
(U1 snRNP) and NOVA. U1 snRNP is part of the core splicing machinery and is essential
for recognition of the 5′ splice site. Nevertheless, in certain contexts, U1 snRNP is a
required component of potent splicing silencers35. NOVA53, a neuron-specific splicing
factor, functions as a positive regulator when positioned upstream of splice sites but a
negative regulator when positioned downstream of affected splice sites. The generalities of
this directionality and the detailed biochemical mechanisms underlying the opposing
functions of both U1 snRNP and NOVA (as well as many other splicing regulators) remain
to be elucidated. But it is clear that context affects function, and this adds a layer of
complexity to the already complex field of alternative and regulated splicing.

Bioinformatics and alternative splicing
One of the most useful tools for studying alternative splicing over the past decade has been
bioinformatics. Computational approaches have become increasingly powerful and
sophisticated with each genome that has been completely sequenced and with each advance
in the technologies used for genomic analysis. The ultimate goal of using bioinformatics in
the splicing field is to be able to identify which exons in a genome are alternatively spliced
from pre-mRNAs, to predict accurately the spatial and temporal pattern in which the exons
are regulated, and to predict which splicing factors are involved in regulating the exons.
These goals have yet to be reached, but there has been considerable progress in these areas,
particularly in the past five years.
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One of the most powerful methods in the bioinformatics toolbox is comparative genomics,
which uses the degree of similarity between two or more genomes to infer functional
information about regions of interest. For instance, this approach revealed that alternative
exons are typically more conserved across species than are constitutive exons54–56,
presumably because of the information content needed to facilitate regulation. This
observation, in turn, has been used to predict whether a particular exon is more likely to be
constitutive or alternative and to identify previously unrecognized alternative exons57.
Comparative genomics has also been used to characterize splicing enhancers or silencers by
identifying sequences that are enriched or depleted in exons or introns58 and by pinpointing
sequences within coding exons (those translated into protein) that are more highly conserved
than expected given the flexibility of the genetic code59. Similarly, comparative genomics
has facilitated the identification of sequences that participate in the formation of the RNA
structures involved in the control of alternative splicing50,51,60.
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Nevertheless, comparative genomic approaches have limitations. Although evolutionary
conservation provides strong evidence for the functional significance of a particular splicing
pattern, the converse is not always true. A particularly notable example is the alternative
splicing cascade that controls sex determination in D. melanogaster11. Although this elegant
pathway is crucial for survival of the species, it shows rapid evolutionary flux. Even among
the closely related Drosophila species, there are subtle but important differences in the
organization and expression of the genes that are involved in this cascade11. Furthermore,
slightly more distantly related insects, such as the housefly (Musca domestica) and the
Mediterranean fruitfly (Ceratitis capitata), do not splice the pre-mRNA corresponding to the
first gene in the sex-determination pathway (Sex lethal) in a sex-specific manner11. Even
more strikingly, almost every component of the sex-determination cascade of D.
melanogaster and the honeybee, Apis mellifera, is different, although the process relies on
alternative splicing in both species61,62.
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These examples show the high level of evolutionary plasticity that alternative splicing
provides. Because small changes (that is, point mutations) in either exons or introns can
create or destroy splicing control elements63, it is easy to envisage that splicing patterns are
constantly evolving: advantageous mutations would rapidly be selected for, and deleterious
mutations would be selected against64. Indeed, we speculate that ‘non-conserved’ changes in
splicing patterns might underlie the observed phenotypic variations between species and
between individuals within species. Recent studies have provided insight into the way in
which human exons have evolved65 and the extent of alternative splicing differences
between humans and chimpanzees66. Additional studies along these lines are likely to
improve the understanding of how alternative splicing contributes to speciation and
phenotypic diversity67.

Outstanding questions
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In addition to the broad questions that we have outlined, numerous issues remain
unresolved. Foremost among these is whether the extent of alternative splicing can account
for organismal complexity. It is noteworthy that Caenorhabditis elegans, D. melanogaster
and mammals have about 20,000 (ref. 68), 14,000 (ref. 69) and 20,000 (ref. 70) genes,
respectively, but mammals are clearly much more complex than nematodes or flies. In the
nervous system alone, nematodes have only a few hundred neurons, whereas mammals have
several billion. Indeed, at present, the absolute amount of alternative splicing that takes
place in mammals4,5 seems to be much higher than in nematodes71 or flies72. These
measures, however, are based on far fewer data in nematodes and flies than in humans.
Thus, completion of the model organism Encyclopedia of DNA Elements (modENCODE)
project73, which seeks to identify all of the sequence-based functional elements in C.
elegans and D. melanogaster, should help to uncover the true extent of alternative splicing in
these organisms. Nonetheless, mammalian neuronal tissue is enriched for alternatively
spliced products compared with other mammalian tissues and, at least in this case, the extent
of alternative splicing correlates with greater complexity.
Another crucial question is how many mRNA isoforms are functionally relevant? Teleology
suggests that if an isoform exists, it is important (similarly to the way in which ‘junk’ DNA
is now considered to be treasure). But this idea is hard to prove and is difficult for some to
accept. Unfortunately, the function of alternative mRNA isoforms has been carefully
analysed for only a small proportion of genes. Such studies have, however, provided
numerous examples in which alternative splicing clearly gives rise to functionally distinct
isoforms (Table 2). But just as discernible changes in phenotype are frequently not observed
even when entire genes are deleted, there are also many cases in which functional
distinctions between mRNA isoforms have not been observed. One example of this is the D.
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melanogaster gene Cadherin-N (CadN), which contains two mutually exclusive versions of
exon 18 (exon 18A and exon 18B). These exons are dynamically regulated throughout
development, expressed in different tissues, and highly conserved throughout evolution.
However, although mutations in exon 18A disrupt development of the R7 photoreceptor,
suggesting that the alternative splicing of CadN pre-mRNA is functionally relevant, this
phenotype can be rescued by expressing an mRNA isoform that contains sequence
corresponding to the other exon, exon 18B74. Therefore, it is formally possible that
alternative splicing of CadN pre-mRNA does not generate functionally distinct isoforms but
ensures that one isoform is expressed at the correct time and place. However, it is also
possible that there are functional distinctions between the isoforms that cannot be detected in
the assays used. Thus, the question of how many alternative splicing events are functionally
relevant is destined to remain unanswered for some time.
Another outstanding question is whether there is a decipherable ‘splicing code’. Will a
computer be able to predict reliably the splicing patterns in a cell or organism? Despite the
numerous variables (known and unknown) involved in splice-site choice, rapid progress has
been made in this area75. But it is not clear when or whether this Rosetta stone of splicing
will emerge.
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It also remains unclear to what extent elements deep within sequences corresponding to
introns (and the factors that bind to them) influence alternative splicing decisions. Most
investigations have focused on elements close to splice sites, but intronic regions that are
distant from the splice sites themselves could almost certainly affect alternative splicing.
Much remains to be learned about the mechanisms of alternative splicing and the regulatory
networks of alternative splicing. It is clear that researchers are only beginning to understand
the diversity and details of the mechanisms that are used to regulate alternative splicing, as
well as the factors involved. Recent technological advances, particularly in genomic
analysis, suggest that the next few years are likely to be filled with many exciting and
unanticipated discoveries that could rapidly reveal the mysteries of the field.
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Figure 1. Types of alternative splicing
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There are four basic types of alternative splicing: alternative 5′ splice-site selection (a),
alternative 3′ splice-site selection (b), cassette-exon inclusion or skipping (c) and intron
retention (d). The rectangles in the centre represent pre-mRNAs. For each pre-mRNA, the
black lines span the regions that can be spliced out, with the lines above corresponding to
the mature mRNA shown on the left and the lines below to the mRNA on the right. That is,
the mRNA that is synthesized when the central exon (or intron in d) is skipped is shown on
the left, and the mRNA that is synthesized when this sequence is included is shown on the
right. In d, the pink portion is considered an exon when included (right) and an intron when
skipped (left).
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Figure 2. The generation of diverse mRNA repertoires
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a, Human KCNMA1 pre-mRNA is depicted, with constitutive exons in blue and alternative
exons in yellow and red. The possible splicing patterns for each exon are indicated above
and below the pre-mRNA (black lines).The KCNMA1 pre-mRNA contains multiple
alternative 5′ splice sites, alternative 3′ splice sites and sequence corresponding to cassette
exons. Together, these allow more than 500 mRNA isoforms to be synthesized from a single
pre-mRNA. b, Drosophila melanogaster Dscam pre-mRNA is depicted, with constitutive
exons in blue and alternative exons in the exon 4, 6, 9 and 17 clusters shown in yellow,
orange, red and purple, respectively. The splicing pattern for one mRNA isoform is shown
as an example. The Dscam gene contains 95 alternative exons organized into four clusters of
mutually exclusive exons (that is, only exon from each cluster is transcribed). These four
clusters are at exon 4, exon 6, exon 9 and exon 17, which contain 12, 48, 33 and 2 variable
exons, respectively. In combination with the 20 constitutive exons of Dscam, this structure
allows 38,016 mRNAs to be synthesized from a single pre- mRNA. c, The organization of
the D. melanogaster gene mod(mdg4) is depicted, with common exons in blue and variable
exons in purple. The common exons and some of the variable exons are present on one
strand of the DNA and are transcribed from left to right as shown, whereas another set of the
variable exons is present on the opposite strand and is transcribed from right to left as
illustrated. The precise number, and the precise positions of the beginnings and ends, of the
common exon pre-mRNA and the variable exon pre-mRNAs is unknown. The possible
splicing patterns for each exon in the corresponding pre-mRNA are indicated by black lines,
with the possible positions of poly(A)+ tails indicated by green wavy lines. A total of 28
mod(mdg4) mRNAs are synthesized, and this occurs through the trans-splicing of the
common exons to one set of variable exons.
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Figure 3. Alternative splicing regulatory mechanisms

a, Kinetic effect of splicing silencers on alternative splicing. Left, when two competing 5′
splice sites are present in a hypothetical pre-mRNA and the appropriate silencer is absent
(that is, the hnRNP, which silences transcription by binding to the exonic splicing silencer
(ESS)), the U1 small nuclear RNP (U1 snRNP) binds to both 5′ splice sites (while U2
snRNP and U2AF bind to the single 3′ splice site), and the proximal 5′ splice site is
preferentially used (solid black line; dashed black line indicates splicing to the distal 5′
splice site). Top right, by comparison, when the hnRNP is present, the rate at which the
proximal 5′ splice site can be used decreases, promoting splicing to the distal 5′ splice site.
Centre right, in comparison with the case on the left, in the absence of a competing 5′ splice
site upstream, the presence of the hnRNP does not significantly decrease the rate of splicing.
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Bottom right, in comparison with the case on the left, when silencer sequences are present
near both 5′ splice sites, the hnRNP has no detectable impact on the ratio at which either
splice site is used. b, Interplay between transcription elongation rate, chromatin structure
and histone modifications, and their impact on alternative splicing. A hypothetical gene is
depicted; three exons are shown packaged into nucleosomes. The constitutively transcribed
exons (green) are packaged into nucleosomes that constitutively contain histone H3 that is
trimethylated (yellow) at lysine residue 36 (H3K36me3). In cells that do not include the
alternative exon (pink) in the mRNA, the nucleosomes packaging this exonic DNA do not
contain H3K36me3 (top). We propose that when RNA polymerase (brown ovals;
spliceosome, orange circle) transcribes a gene with this chromatin configuration (with the
pre-mRNA shown here in grey), it traverses the alternative exon rapidly, and this exon is not
tethered to the RNA polymerase and, accordingly, sequence corresponding to this exon is
not included in the mature mRNA (the splicing of exonic sequences is indicated by curved
arrows). By contrast, when the nucleosome that is packaging the alternative exon contains
H3K36me3, this slows the progress of the RNA polymerase, allowing it to capture the exon,
resulting in the inclusion of sequence corresponding to this sequence in the mature mRNA
(bottom).
c, Kinetic model of mutually exclusive splicing of Dscam pre-mRNA. Mutually exclusive
splicing of the sequence corresponding to the exon 6 cluster of the Dscam gene involves the
formation of secondary structures in the RNA. These structures form between the docking
site in the intronic sequence downstream of the sequence corresponding to exon 5 and a
selector sequence located upstream of each sequence corresponding to an exon 6 variant. In
addition, the hnRNP HRP36 binds to, and represses, all 48 exonic sequences in the cluster.
Which exonic sequence is spliced seems to be a function of kinetic competition between the
48 potential docking-site–selector sequence structures and between SR proteins (not shown)
and HRP36. On the left, the selector sequence upstream of the sequence corresponding to
exon 6.3 in the pre-mRNA interacts with the docking site. HRP36 is then displaced from this
exonic sequence, allowing an SR protein to bind in its place. This results in the inclusion of
sequence corresponding to exon 6.3 in the mRNA. On the right, the formation of a
secondary structure with a more distal sequence means that exon 6.47 is included in the
mRNA instead.
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Table 1

Types and examples of splicing regulatory protein
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Class

Function

Examples*

SR and SR-related proteins

Typically activate splicing, by recruiting
components of the splicing machinery

nSR100 (SRRM4), SC35, SF2 (ASF), SRM160 (SRRM1),
SRp30c, SRp38, SRp40, SRp55, SRp75, TRA2α, TRA2β

hnRNPs

Typically repress splicing, by a variety of
poorly understood mechanisms

hnRNP A1, hnRNP A2/B1, hnRNP C, hnRNP F, hnRNP G
(RBMX), hnRNP H, hnRNP L, nPTB (PTBP2), PTB (PTB1)

Other RNA-binding proteins

Activate or repress splicing
U1 snRNP is essential for constitutive
splicing but can also repress splicing

CELF4 (BRUNOL4), CUGBP, ESRP1, ESRP2, FOX1
(A2BP1), FOX2 (A2BP2), HuD, MBNL1, NOVA1, NOVA2,
PSF (SPFQ), quaking, SAM68 (KHDRBS1), SLM2
(KHDRBS3), SPF45 (RBM17), TIA1, TIAR (TIAL1), U1
snRNP

*

Synonyms are listed in parentheses
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Table 2

Examples of functionally relevant alternative splicing events
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Gene*

Description

Reference

Drosophila melanogaster
Dscam

Alternative splicing has the potential to generate 19,008 extracellular domains that show isoform-specific
homophilic binding, regulating neural wiring and immune-system interactions with pathogens†

76

fru

Sex-specific splicing controls courtship behaviour

77

Nurf301 (E(bx))

Alternative splicing generates three protein isoforms, each of which assembles into a functionally distinct
form of the chromatin-remodelling complex NURF

78

Caenorhabditis elegans
egl-15

Mutually exclusive splicing generates two isoforms of a growth factor with distinct ligand specificities

79

fbl-1

Alternative splicing generates two isoforms of a basement-membrane protein that have distinct but
complementary roles in tissue assembly and organization

80

unc-60

Alternative splicing generates two isoforms of actin-depolymerizing factor (cofilin) that have distinct actinfilament-severing activities

81

NLGN1

Alternative splicing modulates the interactions between the neuronal synaptic cell-adhesion molecules
neuroligin 1 and neurexins

82

SLACK (KCNT1)

Alternative splicing alters the amino-terminal domain of SLACK isoforms, regulating interactions with
SLICK to form a heteromeric sodium-activated potassium channel

83

Alternative splicing generates two protein isoforms that differ in their ability to stabilize synaptic vesicles
in the primed state

84

Homo sapiens
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Mus musculus
Snap25
*

Synonyms are listed in parentheses.

†

There are 19,008 combinations of the extracellular portion (encoded by exons 4, 6 and 9) and two transmembrane domains encoded by the two
variants of exon 17, making 38,016 isoforms.
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